血管质量倡议中心接受腹主动脉瘤腔内修复术的医保患者报销特征
本研究将Medicare索赔数据与血管质量倡议(VQI)临床注册数据链接,分析2003至2015年接受腹主动脉瘤腔内修复术(EVR)的9403例医保患者。结果显示报销额从2003年的37450±9350美元降至2015年的27723±10613美元(趋势检验P<0.001),发生并发症者平均报销44858±23825美元,无并发症者为28857±9258美元(P<0.001)。
要点
- EVR医保报销额在2003至2015年间显著下降。
- 术后并发症使平均报销额近乎翻倍。
- 校正患者因素后,VQI中心间平均报销额存在4倍差异。
核心结论
- 2003至2015年间EVR的医保报销额呈下降趋势。
- 识别了与报销额独立相关的术前临床因素,并量化了不同术后并发症对报销额的影响。
- 中心层面报销额存在显著差异,需进一步研究。
研究设计与样本
- 将Medicare索赔数据与VQI临床注册数据链接,纳入2003至2015年接受EVR且全年由Medicare A和B部分按服务付费全额覆盖并有对应EVR诊断相关组的患者。
- 主要结局为住院医院和专业服务的Medicare报销额,调整至2015年美元。
- 采用描述性分析、单因素分析及多水平回归模型识别与报销额独立相关的因素并量化中心间差异。
主要发现
- 共纳入9403例在VQI中心接受EVR的Medicare患者。
- 报销额从2003年的37450±9350美元降至2015年的27723±10613美元(趋势检验P<0.001)。
- 发生并发症的患者(n=773;8.2%)平均报销额为44858±23825美元,无并发症者为28857±9258美元(P<0.001)。
- 肠缺血、新需要透析和呼吸系统并发症均使Medicare平均报销额翻倍。
- 校正诊断相关组后,与较高报销额独立相关的患者因素包括破裂腹主动脉瘤(+2372美元)、住院时间每增加一天(+1275美元)和不适合开放修复(+501美元)。
临床怎么用
- 临床医生应了解EVR报销额随时间下降的趋势。
- 术后并发症显著增加报销额,提示并发症预防对费用控制的重要性。
- 中心间报销差异提示需进一步研究以优化资源配置。
局限性
- 分析仅限于全年由Medicare按服务付费全额覆盖并有对应诊断相关组的患者。
- 研究为回顾性观察性设计,可能受未测量混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aortic aneurysm repair (EVR) has a major financial impact on health care systems. We characterized reimbursement for index EVR hospitalizations among Medicare beneficiaries having surgery at Vascular Quality Initiative (VQI) centers. METHODS: We linked Medicare claims to VQI clinical registry data for patients undergoing EVR from 2003 to 2015. Analysis was limited to patients fully covered by fee-for-service Medicare parts A and B in the year of their operation and assigned a corresponding diagnosis-related group for EVR. The primary outcome was Medicare's reimbursement for inpatient hospital and professional services, adjusted to 2015 dollars. We performed descriptive analysis of reimbursement over time and univariate analysis to evaluate patient demographics, clinical characteristics, procedural variables, and postoperative events associated with reimbursement. This informed a multilevel regression model used to identify factors independently associated with EVR reimbursement and quantify VQI center-level variation in reimbursement. RESULTS: We studied 9,403 Medicare patients who underwent EVR at VQI centers during the study period. Reimbursements declined from $37,450 ± $9,350 (mean ± standard deviation) in 2003 to $27,723 ± $10,613 in 2015 (test for trend, P < 0.001). For patients experiencing a complication (n = 773; 8.2%), mean reimbursement for EVR was $44,858 ± $23,825 versus $28,857 ± $9,258 for those without complications (P < 0.001). Intestinal ischemia, new dialysis requirement, and respiratory compromise each doubled Medicare's average reimbursement for EVR. After adjusting for diagnosis-related group, several patient-level factors were independently associated with higher Medicare reimbursement; these included ruptured abdominal aortic aneurysm (+$2,372), additional day in length of stay (+$1,275), and being unfit for open repair (+$501). Controlling for patient-level factors, 4-fold variation in average reimbursement was seen across VQI centers. CONCLUSIONS: Reimbursement for EVR declined between 2003 and 2015. We identified preoperative clinical factors independently associated with reimbursement and quantified the impact of different postoperative complications on reimbursement. More work is needed to better understand the substantial variation observed in reimbursement at the center level.
引用
- Trooboff SW, Wanken ZJ, Gladders B, et al. Characterizing Reimbursements for Medicare Patients Receiving Endovascular Abdominal Aortic Aneurysm Repair at Vascular Quality Initiative Centers. Ann Vasc Surg. 2019. PMID: 31610277. doi:10.1016/j.avsg.2019.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。